|Bid||0.3612 x 100|
|Ask||0.3700 x 20700|
|Day's Range||0.3466 - 0.3796|
|52 Week Range||0.3300 - 1.0500|
|PE Ratio (TTM)||-0.56|
|Earnings Date||Mar 7, 2017 - Mar 13, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||0.90|
Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Form S-4 Registration Statement Declared Effective by SEC
MILL VALLEY, Calif., BOTHELL, Wash. and VANCOUVER, British Columbia, June 13, 2017 /PRNewswire/ -- Achieve Life Sciences, Inc. (Achieve) and OncoGenex Pharmaceuticals, Inc. (OGXI) (OncoGenex) today announced that the Registration Statement on Form S-4 has been declared effective by the Securities and Exchange Commission ("SEC") on June 13, 2017. The special meeting of the OGXI stockholders will be held on August 1, 2017, at 9 a.m. PT at 1191 Second Avenue, Floor 10, Seattle, Washington, 98101. OncoGenex will ask its stockholders to approve the merger with Achieve and the issuance of OncoGenex common stock in the merger pursuant to the merger agreement.
BOTHELL, Wash. and VANCOUVER, British Columbia, May 15, 2017 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced financial results for the first quarter ended March 31, 2017. ...